The Moderna vaccine retains antibodies against variants of interest and concern for 6 months. This is the evidence of a new study produced by the American company. Study, published in the journal Science, which highlights precisely how most of the participants who have completed the vaccination cycle maintain detectable neutralizing and functional antibodies against the Alpha, Beta, Gamma, Delta, Epsilon and Iota variants for 6 months.
These data, the company said, complement other recent analyzes based on real data that demonstrate robust clinical efficacy longevity of the Moderna vaccine and efficiency in the face of increasing levels of concern for the Delta variant and in those more categories. ‘difficult to treat, such as people in long-term care facilities or patients living with cancer. “We are pleased with this new data which shows that people vaccinated with two doses of the Moderna Covid-19 vaccine retained the antibodies for six months, even against variants of concern such as Delta. Together with our partners, we are committed to collecting data on the vaccine and to share them when available, “said Stephane Bancel, Moderna’s chief executive. “These data support the 93 percent enduring efficacy seen with the Moderna Covid-19 vaccine for six months. We expect this data and the growing body of real-world evidence to help inform health authority approaches on how and when to administer additional doses, “he concludes.